Given their role in tumor growth and metastasis, platelets are emerging as a potential target for anti-cancer therapies. Researchers are exploring various strategies, such as the use of antiplatelet drugs like aspirin and clopidogrel, to interfere with platelet function and inhibit tumor progression.
